Monday’s market has seen swings in various stocks based on news and other factors. Today, stocks like Regencell Bioscience Holdings (RGC) are rallying, while stocks like AngloGold Ashanti Ltd (AU) are falling. Below are highlights of some of the biggest stock movers, from mega-caps to small caps.
Mega-Cap Movers ($200 billion USD or higher)
- Applovin (APP) -3.37%
- Alibaba-exch (BABA) -3.06%
- Tesla Motors (TSLA) -2.6%
- Micron Tech (MU) +2.1%
Large-Cap Stock Movers ($10-$200 billion USD)
- Regencell Bioscience Holdings (RGC) +19.28%
- AngloGold Ashanti Ltd (AU) -7.45%
- Agnico-Eagle Mines (AEM) -6.42%
- Newmont Mining (NEM) -5.8%
- Coeur dAlene Mines Corp (CDE) -4.59%
- Hecla Mining Comp (HL) -4.11%
- Coca-Cola Bottlin (COKE) -4.34%
- Royal Gold Inc. (RGLD) -3.96%
- Medline Inc (MDLN) -3.61%
- Lumentum Holdings Inc (LITE) -3.99%
Mid-Cap Stock Movers ($2-$10 billion USD)
- Ultragenyx (RARE); Ultragenyx’s bone disorder treatment fails primary endpoints in trials -44.6%
- Mudrick Capital A (HYMC) -11.15%
- Bellring Brands LLC (BRBR) -9.91%
- Aura Minerals NAQ (AUGO) -8.77%
- DRDGOLD Ltd (DRD) -8.76%
- Crocs (CROX) -6.35%
- MSCI Global Gold Miners Fund (RING) -6.73%
- Northstar At Mgt (DBRG); DigitalBridge Group (DBRG) halted following Softbank rumors +9.73%
- Belite Bio ADR (BLTE) +9.51%
- Praxis Precision Medicines Inc (PRAX); FDA grants breakthrough therapy designation for Praxis’s tremor drug +13.53%
Small-Cap Stock Movers ($300 million -$2 billion USD)
- Mereo BioPharma Group (MREO); Mereo’s setrusumab fails primary endpoint in osteogenesis imperfecta trials -87.5%
- Lionheart III (SMX) -31.59%
- Thunder Bridge Capital Partners IV (CNCK) -22.7%
- Cryptyde (ORBS); Eightco authorizes $125 million share buyback program +21.02%
- TryHard Holdings (THH) +29.32%
- Galena Biopharma (SLS); SELLAS reports 72 events in Phase 3 REGAL trial, awaits final analysis +18.29%
- Autolus Therapeutics (AUTL) +14.81%
- Neuralstem (PALI); Piper Sandler initiates Palisade Bio stock with Overweight rating on IBD drug +12.33%
- JATT Acquisition (ZURA) +11.29%
- Prime Acquisition (HPK) +9.6%
For real-time, market-moving news, join Investing Pro.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

























